The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Walitt, Brian ^a   Nahin, Richard L ^a   Katz, Robert S ^b   Bergman, Martin J ^c   Wolfe, Frederick ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CITIZENSHIP; COMORBIDITY; DISEASE ASSOCIATION; DISTRESS SYNDROME; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FIBROMYALGIA; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MIDDLE AGED; MUSCULOSKELETAL DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SATISFACTION; POLYSYMPTOMATIC DISTRESS SCALE; PREDICTION; PREVALENCE; REVIEW; SELF REPORT; SEX DIFFERENCE; UNITED STATES; VERY ELDERLY; WORK CAPACITY; YOUNG ADULT; ADOLESCENT; PAIN; PROCEDURES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL SECURITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; FIBROMYALGIA; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE; RHEUMATOLOGY; SELF REPORT; SEVERITY OF ILLNESS INDEX; SOCIAL SECURITY; YOUNG ADULT;

EID: 84945939474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138024     Document Type: Review

References (59)

1. Wolfe F, Clauw D, Fitzcharles MA, Goldenberg D, Häuser W, Katz RS, et al. Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011; 38: 1113-22. doi: 10.3899/jrheum.100594 PMID: 21285161
2. Wolfe F, Clauw D, Fitzcharles MA, Goldenberg D, Katz RS, Mease P, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res. 2010; 62(5): 600-10.
3. National Center for Health Statistics. Data File Documentation, National Health Interview Survey, 2012 (machine readable data file and documentation). In: Statistics NCfH, editor. Hyattsville, Maryland: Centers for Disease Control and Prevention, ; 2013. p. 1-135.
4. Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: Results from a survey of the general population. Arthitis Care and Research. 2013; 65(5): 777-85. Epub February 19, 2013 (10.1002/acr.21931). doi: 10.1002/acr.21931).
5. Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC, Soriano-Maldonado A, Estévez-López F, Delgado-Fernández M, et al. Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology. 2014: Keu169.
6. Wolfe F, Michaud K. The National Data Bank for rheumatic diseases: A multi-registry rheumatic disease data bank. Rheumatology (Oxford). 2011; 50(1): 16-24. Epub 2010/06/23. keq155 [pii]doi: 10.1093/rheumatology/keq155 PMID: 20566735.
7. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and rheumatism. 1990; 33(2): 160-72. PMID: 2306288.
8. Royston P. Multiple imputation of missing values. Stata Journal. 2004; 4(3): 227-41.
9. Youden WJ. Index for rating diagnostic tests. Cancer. 1950; 3(1): 32-5. PMID: 15405679
10. Organization WH. WHO Expert Committee on Physical Status: The use and interpretation of anthropometry phisical status. Geneva: World Health Organization; 1995. WHO Technical Report Series. 1995; 854.
11. Corporation S. Stata Statistical Software: Release 13.1. College Station, TX: Stata Corporation; 2013.
12. Sacks JJ, Harrold LR, Helmick CG, Gurwitz JH, Emani S, Yood RA. Validation of a surveillance case definition for arthritis. JRheumatol. 2005; 32(2): 340-7. PMID: 15693097.
13. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007; 61(9): 1498-508. Epub 2007/07/28. IJCP1480 [pii] doi: 10.1111/j.1742-1241.2007.01480.x PMID: 17655684.
14. Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, et al. The comparative burden of mild, moderate and severe fibromyalgia: Results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011; 9: 71. doi: 10.1186/1477-7525-9-71 PMID: 21859448
15. Wolfe F, Walitt BT, Katz RS, Häuser W. Social security work disability and its predictors in patients with fibromyalgia. Arthritis care & research. 2014.
16. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006; 124(1-2): 117-25. PMID: 16698181.
17. Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007; 78(2): 88-95. Epub 2007/10/16. PMID: 17933276.
18. McBeth J, Silman AJ. The role of psychiatric disorders in fibromyalgia. CurrRheumatolRep. 2001; 3 (2): 157-64.
19. Jeffery DD, Bulathsinhala L, Kroc M, Dorris J. Prevalence, Health Care Utilization, and Costs of Fibromyalgia, Irritable Bowel, and Chronic Fatigue Syndromes in the Military Health System, 2006-2010. Military medicine. 2014; 179(9): 1021-9. doi: 10.7205/MILMED-D-13-00419 PMID: 25181721
20. Hadler NM, Greenhalgh S. Labeling woefulness: The social construction of fibromyalgia. Spine. 2005; 30(1): 1-4. PMID: 15626973.
21. Wessely S, Hotopf M. Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence. Baillieres BestPractResClinRheumatol. 1999; 13(3): 427-36. PMID: 10562373.
22. Ehrlich GE. Pain is real; fibromyalgia isn't. JRheumatol. 2003; 30(8): 1666-7. PMID: 12913918.
23. Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford). 2010; 49(5): 924-8. doi: 10.1093/rheumatology/kep458 PMID: 20100795.
24. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001; 134(9 Pt 2): 868-81. Epub 2001/05/11. 200105011-00011 [pii]. PMID: 11346323.
25. Dumit J. Illnesses you have to fight to get: Facts as forces in uncertain, emergent illnesses. Social Science & Medicine. 2006; 62(3): 577-90.
26. Fink P, Toft T, Hansen MS, p ?rnb p ?l E, Olesen F. Symptoms and syndromes of bodily distress: An exploratory study of 978 internal medical, neurological, and primary care patients. Psychosomatic Medicine. 2007; 69(1): 30-9. PMID: 17244846
27. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010; 68 (5): 415-26. Epub 2010/04/21. S0022-3999(10)00075-9 [pii]doi: 10.1016/j.jpsychores.2010.02.004 PMID: 20403500.
28. Wessely S, White PD. There is only one functional somatic syndrome. The British Journal of Psychiatry. 2004; 185(2): 95-6.
29. Aronowitz RA. When do symptoms become a disease? Annals of internal medicine. 2001; 134(9 Pt 2): 803. PMID: 11346314
30. Kroenke K. Physical symptom disorder: A simpler diagnostic category for somatization-spectrum conditions. Journal of psychosomatic research. 2006; 60(4): 335-9. PMID: 16581354
31. Kroenke K. Somatoform disorders and recent diagnostic controversies. Psychiatric Clinics of North America. 2007; 30(4): 593-619. PMID: 17938036
32. Maeland S, Werner EL, Rosendal M, Jonsdottir IH, Magnussen LH, Ursin H, et al. Diagnoses of patients with severe subjective health complaints in Scandinavia: A cross sectional study. ISRN Public Health. 2012; 2012.
33. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. JRheumatol. 2004; 31(4): 695-700. PMID: 15088293.
34. Macfarlane GJ, Norrie G, Atherton K, Power C, Jones GT. The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: Results from the 1958 British Birth Cohort Study. Annals of the rheumatic diseases. 2009; 68(10): 1591-5. doi: 10.1136/ard.2008.093088 PMID: 18952642
35. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: An epidemiological study in seven specialities. J Psychosom Res. 2001; 51(1): 361-7. Epub 2001/07/13. S0022-3999(01)00223-9 [pii]. PMID: 11448704.
36. Kleinman A. The illness narratives: Suffering, healing, and the human condition: Basic Books (AZ); 1988.
37. Kirmayer LJ, Sartorius N. Cultural models and somatic syndromes. Psychosomatic Medicine. 2007; 69 (9): 832-40. PMID: 18040090
38. Aceves-Avila FJ, Ferrari R, Ramos-Remus C. New insights into culture driven disorders. Best Pract Res Clin Rheumatol. 2004; 18(2): 155-71. Epub 2004/05/04. doi: 10.1016/j.berh.2004.02.004 S1521694204000300 [pii]. PMID: 15121037.
39. Wolfe F, Hawley D. Evidence of disordered symptom appraisal in fibromyalgia: Increased rates of reported comorbidity and comorbidity severity. Clinical and experimental rheumatology. 1998; 17 (3): 297-303.
40. Nicholl B, Macfarlane G, Davies K, Morriss R, Dickens C, McBeth J. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain: Results from the EPIFUND study. Pain. 2009; 141(1): 119-26.
41. Macfarlane GJ, Morris S, Hunt IM, Benjamin S, McBeth J, Papageorgiou AC, et al. Chronic widespread pain in the community: The influence of psychological symptoms and mental disorder on healthcare seeking behavior. JRheumatol. 1999; 26(2): 413-9. PMID: 9972978.
42. Clauw DJ. Fibromyalgia: A Clinical Review. JAMA. 2014; 311(15): 1547-55. doi: 10.1001/jama.2014. 3266 PMID: 24737367
43. Kendler KS. The Structure of Psychiatric Science. Perspectives. 2014; 171(9).
44. Kendler K. The dappled nature of causes of psychiatric illness: Replacing the organic-functional/hardware-software dichotomy with empirically based pluralism. Molecular psychiatry. 2012; 17(4): 377-88. doi: 10.1038/mp.2011.182 PMID: 22230881
45. Holliday KL, Macfarlane GJ, Nicholl BI, Creed F, Thomson W, McBeth J. Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: Results from the EPIFUND study. Journal of psychosomatic research. 2010; 68(5): 469-74. doi: 10.1016/j.jpsychores.2010.01.024 PMID: 20403506
46. Kato K, Sullivan PF, Evengard B, Pedersen NL. Chronic widespread pain and its comorbidities: A population-based study. ArchInternMed. 2006; 166(15): 1649-54. PMID: 16908799.
47. Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychological medicine. 2009; 39(3): 497. doi: 10.1017/S0033291708003784 PMID: 18578896
48. Buskila D, Sarzi-Puttini P, Ablin JN. The genetics of fibromyalgia syndrome. Pharmacogenomics. 2007; 8(1): 67-74. Epub 2006/12/26. doi: 10.2217/14622416.8.1.67 PMID: 17187510.
49. Wolfe F, Michaud K, Busch RE, Katz RS, Rasker JJ, Shahouri SH, et al. Polysymptomatic distress in patients with rheumatoid arthritis: Understanding disproportionate response and its spectrum. Arthritis care & research. 2014; 66(10): 1465-71.
50. Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, et al. Survey Criteria for Fibromyalgia Independently Predict Increased Postoperative Opioid Consumption after Lower-extremity Joint Arthroplasty: A Prospective, Observational Cohort Study. Anesthesiology. 2013; 119(6): 1434-43. doi: 10.1097/ALN.0b013e3182a8eb1f PMID: 24343289
51. Walitt B, Nahin RL, Katz RS, Bergman M, Wolfe F. Most persons with diagnosed with fibromyalgia do not have the disorder: The expansion of fibromyalgia by misdiagnosis, direct to consumer advertising, and diagnosis desirability. Abstract presented at the 2014 American College of Rheumatology annual meeting, Boston, MA. 2014.
52. Wolinsky H. Disease mongering and drug marketing. EMBO reports. 2005; 6(7): 612-4. PMID: 15995678
53. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: How to stop harming the healthy. Bmj. 2012; 344: E3502. doi: 10.1136/bmj.e3502 PMID: 22645185
54. Moynihan R, Heath I, Henry D. Selling sickness: The pharmaceutical industry and disease mongering-Commentary: Medicalisation of risk factors. Bmj. 2002; 324(7342): 886-91. PMID: 11950740
55. Barker KK. Listening to Lyrica: Contested illnesses and pharmaceutical determinism. Social Science & Medicine. 2011; 73(6): 833-42.
56. Epstein SA, Kay G, Clauw D, Heaton R, Klein D. Psychiatric Disorders in Patients With Fibromyalgia: : A Multicenter Investigation. Psychosomatics. 1999; 40(1): 57-63. PMID: 9989122
57. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ. Features of somatization predict the onset of chronic widespread pain: Results of a large population-based study. Arthritis and rheumatism. 2001; 44(4): 940-6. Epub 2001/04/24. doi: 10.1002/1529-0131(200104)44: 43.0.CO;2-S PMID: 11315933.
58. English B. Neural and Psychosocial Mechanisms of Pain Sensitivity in Fibromyalgia. Pain Management Nursing. 2014; 15(2): 530-8. doi: 10.1016/j.pmn.2012.07.009 PMID: 24882030
59. Wolfe F, Walitt BT, Rasker JJ, Katz RS, Hauser W. The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity. The Journal of rheumatology. 2015. doi: 10. 3899/jrheum.141519 PMID: 26077414.